ALNY Market Cap & Key Metrics
Alnylam Pharmaceuticals, Inc.
$224.47
+$0.65(+0.29%)
34
Overall
20
Value
18
Tech
65
Quality
Market Cap
$30.04B
Volume
1.11M
52W Range
$197.81 - $495.55
Target Price
$377.39
ALNY market cap is $30.04B. This page lists Alnylam Pharmaceuticals, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
ALNY Key Metrics
- Market cap
- $30.04B
- P/E ratio (current-year EPS estimate)
- 33.60
- EPS estimate, current year
- $6.68
- EPS growth, 3-year
- +31.17%
- Value score
- 20
- Quality score
- 65
- Technical score
- 18
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $3.71B | $2.25B | $1.83B | $1.04B | $1.51B |
| EBITDA | $631.44M | -$178.85M | -$258.24M | -$929.94M | -$619.43M |
| EPS | $2.39 | $-2.18 | $-3.52 | $-9.30 | $-7.20 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ALNY | $224.47 | +0.3% | 1.11M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Alnylam Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW